Aethlon Medical
AEMD
18 hedge funds and large institutions have $1.43M invested in Aethlon Medical in 2021 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 2 closing their positions.
300% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 2
75% more capital invested
Capital invested by funds: $816K → $1.43M (+$611K)
50% more funds holding
Funds holding: 12 → 18 (+6)
0% more ownership
Funds ownership: 0% → 0.01% (+0%)
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$737K |
| 2 |
VF
Virtu Financial
New York
|
+$48.1K |
| 3 |
FMBTD
First Midwest Bank Trust Division
Joliet,
Illinois
|
+$36.6K |
| 4 |
Millennium Management
New York
|
+$36.6K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$34.6K |
Top Sellers
| 1 |
SSA
Schonfeld Strategic Advisors
New York
|
-$41K |
| 2 |
SPC
Sigma Planning Corp
Ann Arbor,
Michigan
|
-$28K |
AEMD Hedge Fund Activity: Q1 2021 in Review
18 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q1 2021, worth a combined $1.43M — up 75% from $816K a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new AEMD positions and 2 closed out — a net gain of 6 holders — while 2 added to existing stakes and 0 trimmed.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $737K. The largest seller was Schonfeld Strategic Advisors, exiting entirely with an estimated $41K sold.
- 18 institutional investors held Aethlon Medical (AEMD) as of Q1 2021, up from 12 in Q4 2020.
- Funds reported $1.43M of Aethlon Medical stock for Q1 2021, up 75% quarter-over-quarter.
- 8 funds opened new Aethlon Medical positions in Q1 2021 and 2 closed out, a net change of +6 holders.
- The largest Aethlon Medical buyer in Q1 2021 was Renaissance Technologies, an estimated $737K added.
- The largest Aethlon Medical seller in Q1 2021 was Schonfeld Strategic Advisors, an estimated $41K sold.
Based on aggregated 13F filings for Q1 2021.